Browse by Audience
Skip to content
Papers of the Week
Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with Neuropathic Corneal Pain.
Abstract
Neuropathic corneal pain (NCP) is caused, by damage or disease of the somatosensory nervous system that innervates the cornea and presents with symptoms of pain or persistent unpleasant sensations, such as burning, dryness, or light sensitivity. This retrospective study aims to assess the efficacy and tolerability of low-dose naltrexone (LDN) in refractory NCP patients.